368.98MMarket Cap-70444P/E (TTM)
6.460High6.175Low1.04MVolume6.410Open6.350Pre Close6.56MTurnover1.99%Turnover Ratio158.50P/E (Static)58.20MShares6.76052wk High0.68P/B331.31MFloat Cap3.29552wk Low--Dividend TTM52.26MShs Float33.440Historical High--Div YieldTTM4.49%Amplitude0.450Historical Low6.305Avg Price1Lot Size
Vanda Pharmaceuticals Stock Forum
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
Cycle Pharmaceuticals Announces All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 per Share
Benzinga· 1 min ago
Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
Vanda Pharmaceuticals has announced its participation in SLEEP 2024, a conference set to take place in Houston, TX from June 1-5, 2024. The company will present four research studies on June 4, 2024, conducted by Dr. Sandra Paulina Smieszek, Head of Genetics. The presentations will cover drug and CRISPR/Cas9 screening of HCN channels, the impact of melanopsin crispants in zebrafish on sleep latency...
No comment yet